Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Ранг среди акций #41303
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Цена акции
$0.0003
Последняя синхронизация: 2023-06-13
Рыночная капитализация
$28.14K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Neuropathix, Inc. (NPTX)

Категория

EPS для Neuropathix, Inc. (NPTX)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Neuropathix, Inc., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Neuropathix, Inc. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE